Published: June 19th 2024 | Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: August 25th 2025 | Updated: August 26th 2025
BeOne Medicines Announces $950 Million Royalty Purchase Agreement with Royalty Pharma for Imdelltra
Published: August 1st 2025 | Updated: August 26th 2025
New Data Reveals What’s Behind Delays and Denials in RA Care
Published: August 1st 2025 | Updated: August 26th 2025
How One Brand Protected Market Share Amid Biosimilar Pressure
Published: August 1st 2025 | Updated: August 26th 2025
How One Neuro Brand Cut Through Prior Auth Barriers
Published: August 25th 2025 | Updated: August 26th 2025
Valneva Reveals FDA’s Decision to Suspend Ixchiq’s License in the U.S.